Get the latest Science News and Discoveries
Harnessing RNAi: Alnylam’s Path From Lab Discovery to Life-Changing Treatments
The Journey From Research Discovery to Impactful New Treatments Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has developed five FDA-approved RNAi medicines, significantly impacting patient lives. The company continues to innovate in RNAi delivery, aiming to treat various
None
Or read this on SciTech Daily